Conversely, it was reported in the context of type II diabetes and fatty liver disease that increased phosphorylation of AKT was an indicator of insulin response and consequently a good prognostic marker for reduced steatosis (Vivero et al, 2021). Here, AKT1 is linked to type 2 diabetes mellitus.